Literature DB >> 24014165

Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Randi Melissa Schuster1, Raul Gonzalez.   

Abstract

Although the prevalence of neurocognitive disturbances among individuals with HIV has decreased in recent years, rates of impairment still remain high. This review presents findings from comorbid conditions that may contribute to further neurocognitive impairments in this already vulnerable population. We will focus on three co-factors that have received substantial attention in the neuroAIDS literature: drug use, hepatitis C co-infection (HCV), and aging. All three conditions commonly co-occur with HIV and likely interact with HIV in complex ways. Collectively, the extant literature suggests that drug use, HCV, and aging serve to worsen the neurocognitive profile of HIV through several overlapping mechanisms. A better understanding of how specific comorbidities interact with HIV may reveal specific phenotypes of HIV-associated neurocognitive disorder that may aid in the development of more targeted behavioral and pharmacological treatment efforts.

Entities:  

Keywords:  Aging; HIV; HIV Co-Factors; Hepatitis C; Neurocognition; Substance Use

Year:  2012        PMID: 24014165      PMCID: PMC3763847          DOI: 10.2147/NBHIV.S17408

Source DB:  PubMed          Journal:  Neurobehav HIV Med        ISSN: 1179-1497


  261 in total

1.  Abnormal brain activity in prefrontal brain regions in abstinent marijuana users.

Authors:  Dana A Eldreth; John A Matochik; Jean L Cadet; Karen I Bolla
Journal:  Neuroimage       Date:  2004-11       Impact factor: 6.556

2.  Oxidative stress and protein oxidation in the brain of water drinking and alcohol drinking rats administered the HIV envelope protein, gp120.

Authors:  Ashok K Singh; Shveta Gupta; Yin Jiang
Journal:  J Neurochem       Date:  2007-12-06       Impact factor: 5.372

3.  Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor.

Authors:  P K Peterson; G Gekker; S Hu; J Lokensgard; P S Portoghese; C C Chao
Journal:  Neuropharmacology       Date:  1999-02       Impact factor: 5.250

4.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

5.  fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence.

Authors:  Christina S Meade; Steven B Lowen; Robert R MacLean; Mary D Key; Scott E Lukas
Journal:  Psychiatry Res       Date:  2011-05-04       Impact factor: 3.222

6.  Cognitive functioning in younger and older HIV-1-infected adults.

Authors:  Frances L Wilkie; Karl Goodkin; Imad Khamis; Maria H van Zuilen; Diana Lee; Robert Lecusay; Mauricio Concha; Stephen Symes; Paola Suarez; Carl Eisdorfer
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

7.  Premature aging of T cells is associated with faster HIV-1 disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Rita B Effros; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

8.  Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients.

Authors:  K M Fairfield; D M Eisenberg; R B Davis; H Libman; R S Phillips
Journal:  Arch Intern Med       Date:  1998-11-09

9.  Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Donald E Sykes; Jessica L Reynolds; B Bindukumar; Adaffaras Adal; Mingshen Qi; Jennifer Toh; Gaixia Xu; Paras N Prasad; Stanley A Schwartz
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

10.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  9 in total

Review 1.  Depression in HIV infected patients: a review.

Authors:  Maria Giulia Nanni; Rosangela Caruso; Alex J Mitchell; Elena Meggiolaro; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

2.  Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection.

Authors:  L Ene; T D Marcotte; A Umlauf; C Grancea; A Temereanca; A Bharti; C L Achim; S Letendre; S M Ruta
Journal:  J Neuroimmunol       Date:  2016-08-04       Impact factor: 3.478

3.  Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life.

Authors:  Alan T Rodriguez-Penney; Jennifer E Iudicello; Patricia K Riggs; Katie Doyle; Ronald J Ellis; Scott L Letendre; Igor Grant; Steven Paul Woods
Journal:  AIDS Patient Care STDS       Date:  2013-01       Impact factor: 5.078

Review 4.  HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities.

Authors:  Ellen M Tedaldi; Nancy L Minniti; Tracy Fischer
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

5.  Exploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDS.

Authors:  Jennifer M Attonito; Jessy G Dévieux; Brenda D G Lerner; Michelle M Hospital; Rhonda Rosenberg
Journal:  Front Public Health       Date:  2014-08-11

Review 6.  When do models of NeuroAIDS faithfully imitate "the real thing"?

Authors:  Benjamin B Gelman; Janice Endsley; Dennis Kolson
Journal:  J Neurovirol       Date:  2017-12-18       Impact factor: 2.643

7.  Misdiagnosis of HIV With Toxoplasmosis Encephalopathy With Progressive Memory Loss as the Initial Symptom: A Case Report.

Authors:  Jingjing Wu; Xiumei Luo; Nanqu Huang; Yuanyuan Li; Yong Luo
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

8.  A descriptive analysis of concurrent alcohol and substance use among patients living with HIV/HCV co-infection.

Authors:  Omar T Sims; Kaiying Wang; Rasheeta Chandler; Pamela A Melton; Duong N Truong
Journal:  Soc Work Health Care       Date:  2020-09-02

Review 9.  Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders.

Authors:  Amila Omeragic; Olanre Kayode; Md Tozammel Hoque; Reina Bendayan
Journal:  Fluids Barriers CNS       Date:  2020-07-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.